COPD and asthma devices market is expected to reach $51,628.58 million by 2027, registering a CAGR of 4% during 2021-2027. Chronic obstructive pulmonary disease (COPD) and asthma devices are used as permanent treatment or rescue therapy for respiratory diseases and other related diseases. In addition, COPD and asthma are respiratory diseases that cause shortness of […]
